Needham & Company
-
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
-
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
-
Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference
-
Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference
-
Needham & Company Reiterates Buy Rating on Pacira Pharmaceuticals (PCRX)
-
Needham & Company Reiterates Buy Rating, $84 PT on Pacira Pharmaceuticals (PCRX), Continue to Expect Significant Sales Growth Rebound
-
Pacira Pharmaceuticals (PCRX) PT Raised to $84 at Needham & Company
-
Pre-Open Stock Movers 10/11: (PTGX) (ADMS) (FLXN) Higher; (HYLN) (LUV) (NET) Lower (more...)
-
Pacira Pharmaceuticals (PCRX) PT Lowered to $80 at Needham & Company
-
Pacira Pharmaceuticals (PCRX) PT Lowered to $82 at Needham & Company, Following Earnings
-
Pacira Pharma (PCRX) PT Raised to $64 At Needham
-
Companies with NDRs 12/18
-
Pacira Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference
-
Pacira Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference
-
Pacira Pharmaceuticals (PCRX) PT Raised to $60 at Needham & Company
-
Needham & Company Upgrades Pacira Pharmaceuticals (PCRX) to Buy; 'All Signs Point to a Significant Exparel Growth Inflection'
-
Needham & Company Downgrades Pacira Pharmaceuticals (PCRX) to Hold
-
Pre-Open Movers 08/22: (DSW (RT) (JASO) Higher; (TEAR) (CMCM) (NDSN) Lower (more...)
-
After-Hours Stock Movers 08/21: (RT) (PCRX) Higher; (TEAR) (NDSN) (FN) Lower (more...)
-
UPDATE: Needham & Company Starts Pacira Pharmaceuticals (PCRX) at Buy
-
Pacira Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference

